DRRX

アフターアワーズ： 1.42 -0.05 -3.40%

Durect Corp (DRRX)

概要ニュース株価時系列オプションチェーン Financials なぜDRRXが下落しているのか？ディスカッション予測株式分割

Relative Volume:

ネットキャッシュフロー:

Durect Corp Stock (DRRX) Company Profile

Healthcare (1182)

(408) 777-1417

10240 BUBB ROAD, CUPERTINO, CA

DRRX's Discussions on Twitter

Durect Corp Stock (DRRX) Upgrades & Downgrades

日付	アクション	アナリスト	評価の変更
2020-10-30	開始されました	Chardan Capital Markets	Buy
2020-10-12	開始されました	ROTH Capital	Buy
2020-07-31	開始されました	Oppenheimer	Outperform
2020-01-31	開始されました	B. Riley FBR	Buy
2019-11-18	再開されました	Cantor Fitzgerald	Overweight
2019-09-06	開始されました	Cantor Fitzgerald	Overweight
2018-03-06	アップグレード	H.C. Wainwright	Neutral → Buy
2017-10-20	ダウングレード	H.C. Wainwright	Buy → Neutral
2017-10-20	繰り返されました	Laidlaw	Buy
2017-10-20	ダウングレード	Stifel	Buy → Hold
2017-07-12	アップグレード	Stifel	Hold → Buy
2017-02-28	再開されました	H.C. Wainwright	Buy
2016-04-25	開始されました	Rodman & Renshaw	Buy
2015-05-01	繰り返されました	Cantor Fitzgerald	Buy
2015-05-01	繰り返されました	Stifel	Buy
2013-03-25	開始されました	Stifel	Buy
2012-11-01	ダウングレード	C.K. Cooper	Buy → Hold
2012-08-17	開始されました	C.K. Cooper	Buy
2009-06-23	開始されました	Caris & Company	Buy
2009-03-26	開始されました	Wedbush Morgan	Hold

Durect Corp (DRRX) 最新ニュース

Durect Corp (DRRX) 財務データ

Durect Corp (DRRX)

Durect Corp Stock (DRRX) Company Profile

Durect Corp Stock (DRRX) Upgrades & Downgrades

Durect Corp (DRRX) 最新ニュース

DRRXDurect Corp Latest Stock News & Market Updates - StockTitan

DURECT Corporation to Present Data on Larsucosterol at The Liver Meeting 2024 - StockTitan

Durect Corp (DRRX) Q2 2024 Earnings Call Highlights: Revenue Gro - GuruFocus.com

Durect Corp (DRRX) Q2 2024 Earnings Call Highlights: Revenue Growth and Strategic Advances Amid ... - Yahoo Finance

Durect Corp Annual Meeting Decisions and Shareholder Votes - TipRanks

H.C. Wainwright maintains Neutral rating on Durect shares post FDA meeting - Investing.com

DURECT Corporation Announces Phase 3 Registrational Trial Design for Larsucosterol in Alcohol-associated Hepatitis - PR Newswire

DURECT Corporation to Present at the H.C. Wainwright Global Investment Conference - PR Newswire

Durect Corp (NQ: DRRX - Financial Content

Durect (FRA:DC8A) Total Inventories : €2.30 Mil (As of Jun. 2024) - GuruFocus.com

DURECT Co. (NASDAQ:DRRX) Expected to Post Q3 2024 Earnings of ($0.14) Per Share - Defense World

HC Wainwright Analysts Reduce Earnings Estimates for DURECT Co. (NASDAQ:DRRX) - Defense World

DURECT Corporation (NASDAQ:DRRX) Q2 2024 Earnings Call Transcript - Insider Monkey

Earnings call: DURECT Corp reports steady Q2 financials, plans Phase III trial - Investing.com India

Durect: Q2 Earnings Snapshot - Houston Chronicle

Durect (DRRX) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance

DURECT Corporation Reports Second Quarter 2024 Financial Results and Business Update - PR Newswire

DURECT (DRRX) Set to Announce Quarterly Earnings on Tuesday - Defense World

DURECT Co. (NASDAQ:DRRX) Receives $27.50 Average Target Price from Brokerages - American Banking and Market News

DURECT Corporation to Announce Second Quarter 2024 Financial Results and Provide a Business Update - StockTitan

ProAssurance Co. (NYSE:PRA) Shares Bought by CANADA LIFE ASSURANCE Co - Defense World

DURECT (DRRX) Stock Price, News & Analysis - MarketBeat

Altair Engineering (NASDAQ:ALTR) Stock Rating Lowered by The Goldman Sachs Group - Defense World

DURECT (NASDAQ:DRRX) Stock Price Passes Above Two Hundred Day Moving Average of $1.13 - MarketBeat

DURECT Co. (NASDAQ:DRRX) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World

DURECT (NASDAQ:DRRX) Stock Price Passes Above 200-Day Moving Average of $1.01 - Defense World

Durect - The Pharma Letter

DURECT Corporation Announces Presentations in Upcoming Investor Conferences - Quantisnow

DURECT Corporation Reports Second Quarter 2023 Financial Results and Business Update - Quantisnow

DURECT Corporation Reports Third Quarter 2023 Financial Results and Business Update - Quantisnow

DURECT Corporation Announces $15 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules - Quantisnow

DURECT Corporation Announces Last Patient Last Visit in Phase 2b AHFIRM Trial of Larsucosterol in Alcohol ... - Quantisnow

DURECT Corporation to Announce First Quarter 2024 Financial Results and Provide a Business Update - Quantisnow

Are Medical Stocks Lagging DURECT (DRRX) This Year? - Yahoo Canada Finance

Short Interest in DURECT Co. (NASDAQ:DRRX) Increases By 15.1% - MarketBeat

DURECT Co. (NASDAQ:DRRX) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat

DURECT Co. (NASDAQ:DRRX) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World

Drug ManufacturersOther Equities Technical Momentum -- DepoMed, Pernix Therapeutics Holdings, Novo Nordisk ... - br.ADVFN.com

DURECT Corporation Announces Update on DUR-928 Development Program - br.ADVFN.com

Financial Metrics Exploration: Understanding Durect Corp (DRRX) Through Ratios – DWinneX - The Dwinnex

DURECT (NASDAQ:DRRX) Stock Crosses Above Two Hundred Day Moving Average of $0.86 - Defense World

Durect Corp’s Mixed Bag: Up 110.54% in 6 Months, Up 60.25% in 30 Days - The InvestChronicle

Durect stock eyes by H.C Wainwright despite FDA's breakthrough drug designation - Investing.com

FDA grants Breakthrough Therapy status for DURECT's larsucosterol - Investing.com

DURECT gets FDA breakthrough therapy status for larsucosterol (NASDAQ:DRRX) - Seeking Alpha

DURECT Corporation Receives FDA Breakthrough Therapy Designation for Larsucosterol in Alcohol-Associated ... - Yahoo Finance

DURECT Corporation Receives FDA Breakthrough Therapy Designation for Larsucosterol in Alcohol-Associated Hepatitis - PR Newswire

U.S. shares mixed at close of trade; Dow Jones Industrial Average down 0.12% - MSN

U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.12% - MSN

Q2 2024 EPS Estimates for DURECT Co. Lifted by Analyst (NASDAQ:DRRX) - Defense World

DURECT Co. to Post FY2024 Earnings of ($0.90) Per Share, Northland Capmk Forecasts (NASDAQ:DRRX) - Defense World

Durect Corp (DRRX) 財務データ

収益

当期純利益

現金流量

EPS

DRRXに似た銘柄